Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Aptorum Group - 7 Year Stock Price History | APM

Historical daily share price chart and data for Aptorum Group since 2018 adjusted for splits and dividends. The latest closing stock price for Aptorum Group as of August 08, 2025 is 1.26.
  • The all-time high Aptorum Group stock closing price was 325.50 on June 04, 2019.
  • The Aptorum Group 52-week high stock price is 7.49, which is 494.4% above the current share price.
  • The Aptorum Group 52-week low stock price is 0.46, which is 63.5% below the current share price.
  • The average Aptorum Group stock price for the last 52 weeks is 1.35.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Aptorum Group Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 1.1008 2.2000 2.2000 0.7100 1.2600 -55.00%
2024 3.3367 2.1900 10.5500 0.5460 2.8000 14.35%
2023 2.7919 5.1010 5.8000 1.4500 2.4486 -55.49%
2022 12.3100 15.0000 22.8000 4.2198 5.5010 -63.33%
2021 26.9964 24.8000 41.7000 15.0000 15.0000 -39.27%
2020 47.1199 136.6000 160.0000 12.2000 24.7000 -84.42%
2019 175.3589 156.4000 325.5000 129.1000 158.4990 4.41%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.007B $0.000B
Aptorum Group Limited is a pharmaceutical company. It engaged in developing and commercializing therapeutic and diagnostic technologies to tackle unmet medical needs. The company's therapeutic and diagnostic project primarily includes neurology, infectious diseases, gastroenterology, oncology and other disease areas. Aptorum Group Limited is based in Connaught Road, Hong Kong.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $67.696B 26.04
Zoetis (ZTS) United States $65.303B 23.69
Daiichi Sankyo, - (DSNKY) Japan $46.222B 23.69
Takeda Pharmaceutical (TAK) Japan $45.947B 9.38
BeOne Medicines - (ONC) Cayman Islands $31.585B 0.00
Sandoz Group AG (SDZNY) Switzerland $25.846B 0.00
Summit Therapeutics (SMMT) United States $21.285B 0.00
Merck (MKKGY) Germany $16.407B 10.67
Shionogi (SGIOY) Japan $15.227B 0.00
United Therapeutics (UTHR) United States $13.600B 11.77
Neurocrine Biosciences (NBIX) United States $12.399B 36.99
Orion OYJ (ORINY) Finland $10.757B 25.92
IPSEN (IPSEY) France $10.413B 0.00
Madrigal Pharmaceuticals (MDGL) United States $7.676B 0.00
Corcept Therapeutics (CORT) United States $7.618B 63.98
Grifols, S.A (GRFS) Spain $7.329B 0.00
Stevanato Group S.p.A (STVN) Italy $7.156B 42.20
Ionis Pharmaceuticals (IONS) United States $6.637B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.853B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.141B 17.65
Soleno Therapeutics (SLNO) United States $4.376B 0.00
Hypermarcas (HYPMY) Brazil $2.869B 21.57
NewAmsterdam Pharma (NAMS) Netherlands $2.842B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.677B 12.75
Crinetics Pharmaceuticals (CRNX) United States $2.529B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.431B 8.14
Centessa Pharmaceuticals (CNTA) United Kingdom $2.274B 0.00
Ocular Therapeutix (OCUL) United States $2.124B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.742B 0.00
ARS Pharmaceuticals (SPRY) United States $1.719B 0.00
Dyne Therapeutics (DYN) United States $1.588B 0.00
Evotec AG (EVO) Germany $1.396B 0.00
Guardian Pharmacy Services (GRDN) United States $1.264B 0.00
Harrow (HROW) United States $1.263B 0.00
Xeris Biopharma Holdings (XERS) United States $1.105B 0.00
Collegium Pharmaceutical (COLL) United States $1.100B 6.01
Akebia Therapeutics (AKBA) United States $0.907B 0.00
Cronos Group (CRON) Canada $0.883B 0.00
Enliven Therapeutics (ELVN) United States $0.868B 0.00
ProKidney (PROK) United States $0.758B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.681B 0.00
Zevra Therapeutics (ZVRA) United States $0.657B 0.00
Siga Technologies (SIGA) United States $0.642B 7.93
Elite Pharmaceuticals (ELTP) United States $0.626B 0.00
KalVista Pharmaceuticals (KALV) United States $0.620B 0.00
Organogenesis (ORGO) United States $0.578B 0.00
Theravance Biopharma (TBPH) United States $0.576B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.569B 5.86
Bioventus (BVS) United States $0.568B 13.84
Relay Therapeutics (RLAY) United States $0.555B 0.00
Tourmaline Bio (TRML) United States $0.532B 0.00
USANA Health Sciences (USNA) United States $0.527B 10.81
Xencor (XNCR) United States $0.516B 0.00
Oruka Therapeutics (ORKA) United States $0.490B 0.00
Savara (SVRA) United States $0.456B 0.00
Esperion Therapeutics (ESPR) United States $0.371B 0.00
Nanobiotix S.A (NBTX) France $0.354B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.342B 0.00
AleAnna (ANNA) United States $0.325B 0.00
Aldeyra Therapeutics (ALDX) United States $0.315B 0.00
Larimar Therapeutics (LRMR) United States $0.296B 0.00
Nektar Therapeutics (NKTR) United States $0.286B 0.00
Altimmune (ALT) United States $0.280B 0.00
Nature's Sunshine Products (NATR) United States $0.273B 17.82
Galectin Therapeutics (GALT) United States $0.263B 0.00
4D Molecular Therapeutics (FDMT) United States $0.261B 0.00
OmniAb (OABI) United States $0.241B 0.00
Heron Therapeutics (HRTX) United States $0.201B 0.00
MediWound (MDWD) Israel $0.201B 0.00
China SXT Pharmaceuticals (SXTC) China $0.184B 0.00
Aclaris Therapeutics (ACRS) United States $0.177B 0.00
Journey Medical (DERM) United States $0.176B 0.00
Lyell Immunopharma (LYEL) United States $0.170B 0.00
MEI Pharma (MEIP) United States $0.168B 0.00
Profound Medical (PROF) Canada $0.166B 0.00
Lexeo Therapeutics (LXEO) United States $0.150B 0.00
Korro Bio (KRRO) United States $0.150B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.145B 22.42
Protara Therapeutics (TARA) United States $0.121B 0.00
Liminatus Pharma (LIMN) United States $0.115B 0.00
Avita Medical (RCEL) United States $0.112B 0.00
Innate Pharma SA (IPHYF) France $0.110B 0.00
Inhibikase Therapeutics (IKT) United States $0.106B 0.00
Cassava Sciences (SAVA) United States $0.105B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.103B 0.00
Champions Oncology (CSBR) United States $0.088B 20.03
VAXART, INC (VXRT) United States $0.087B 0.00
Achieve Life Sciences (ACHV) Canada $0.087B 0.00
ESSA Pharma (EPIX) Canada $0.085B 0.00
Dominari Holdings (DOMH) United States $0.084B 0.00
Arch Biopartners (ACHFF) Canada $0.082B 0.00
Surrozen (SRZN) United States $0.082B 0.00
Vivani Medical (VANI) United States $0.082B 0.00
Cardiol Therapeutics (CRDL) Canada $0.082B 0.00
Nutriband (NTRB) United States $0.080B 0.00
PMV Pharmaceuticals (PMVP) United States $0.078B 0.00
Metagenomi (MGX) United States $0.072B 0.00
BioNxt Solutions (BNXTF) Canada $0.071B 0.00
Pyxis Oncology (PYXS) United States $0.066B 0.00
Context Therapeutics (CNTX) United States $0.065B 0.00
Inotiv (NOTV) United States $0.063B 0.00
Wellgistics Health (WGRX) United States $0.061B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.059B 0.00
DURECT (DRRX) United States $0.058B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.058B 0.00
Rafael Holdings (RFL) United States $0.057B 0.00
Unicycive Therapeutics (UNCY) United States $0.052B 0.00
PolyPid (PYPD) Israel $0.051B 0.00
Prelude Therapeutics (PRLD) United States $0.048B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.048B 29.36
Plus Therapeutics (PSTV) United States $0.048B 0.00
Fractyl Health (GUTS) United States $0.047B 0.00
Telomir Pharmaceuticals (TELO) United States $0.046B 0.00
Gain Therapeutics (GANX) United States $0.045B 0.00
Century Therapeutics (IPSC) United States $0.044B 0.00
NRx Pharmaceuticals (NRXP) United States $0.044B 0.00
Klotho Neurosciences (KLTO) United States $0.042B 0.00
Jupiter Neurosciences (JUNS) United States $0.040B 0.00
Acrivon Therapeutics (ACRV) United States $0.039B 0.00
FibroGen (FGEN) United States $0.035B 0.00
ElectroCore (ECOR) United States $0.035B 0.00
Karyopharm Therapeutics (KPTI) United States $0.034B 0.00
Scienture Holdings (SCNX) United States $0.034B 0.00
Enlivex Therapeutics (ENLV) Israel $0.034B 0.00
SCYNEXIS (SCYX) United States $0.034B 0.00
Iterum Therapeutics (ITRM) Ireland $0.032B 0.00
Mural Oncology (MURA) Ireland $0.028B 0.00
Tempest Therapeutics (TPST) United States $0.027B 0.00
Vivos Therapeutics (VVOS) United States $0.026B 0.00
Cosmos Health (COSM) United States $0.023B 0.00
Natural Alternatives (NAII) United States $0.023B 0.00
CASI Pharmaceuticals (CASI) China $0.020B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.020B 0.00
Relmada Therapeutics (RLMD) United States $0.020B 0.00
Mannatech (MTEX) United States $0.016B 0.00
Lipocine (LPCN) United States $0.016B 0.00
BioLineRx (BLRX) Israel $0.015B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.013B 0.00
Ainos (AIMD) United States $0.013B 0.00
Citius Pharmaceuticals (CTXR) United States $0.013B 0.00
Incannex Healthcare (IXHL) Australia $0.013B 0.00
ProPhase Labs (PRPH) United States $0.013B 0.00
Ernexa Therapeutics (ERNA) United States $0.013B 0.00
TherapeuticsMD (TXMD) United States $0.012B 0.00
Carisma Therapeutics (CARM) United States $0.011B 0.00
Phio Pharmaceuticals (PHIO) United States $0.011B 0.00
Lyra Therapeutics (LYRA) United States $0.011B 0.00
Mangoceuticals (MGRX) United States $0.010B 0.00
TransCode Therapeutics (RNAZ) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Talphera (TLPH) United States $0.008B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.007B 0.00
Nuvilex (PMCB) United States $0.006B 0.00
VYNE Therapeutics (VYNE) United States $0.005B 0.00
Conduit Pharmaceuticals (CDT) United States $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
Indaptus Therapeutics (INDP) United States $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
BioVie (BIVI) United States $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
SHINECO (SISI) China $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.001B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Indivior (INDV) United States $0.000B 12.36
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 2.15
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00